Faulkner Eric 4
4 · CNS Pharmaceuticals, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Faulkner Eric
Chief Technology Officer
Transactions
- Award
Restricted Stock Units
[F1][F3][F2]2026-03-02+9,500→ 9,500 totalExp: 2036-03-02→ Common Stock (9,500 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Company common stock.
- [F2]The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.
- [F3]Issued in connection with the reporting person's employment with the Company.
Signature
/s/ Christopher Downs, Attorney-in-fact|2026-03-04